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Objective: Abdominal aortic aneurysms (AAAs) are associated with oxidative stress and inﬂammatory response.
We investigated the hypothesis that the known antioxidant ascorbic acid, which can also promote elastin and collagen
production by smooth muscle cells, would prevent AAA formation in a rat model.
Methods: An intraluminal elastase and extraluminal calcium chloride-induced rat AAA model was used, and the animals
were divided into three groups: control (group C, n[ 18), the aorta wrapped with a saline-impregnated gelatin hydrogel
sheet (group G, n [ 18), and the aorta wrapped with a gelatin hydrogel sheet incorporating ascorbic acid (group A,
n[ 18). Wrapping of the sheet was completed at the end of treatment for AAA creation. The aortic dilatation ratio was
measured, and aortic tissues were further examined for oxidative stress and oxidative DNA damage using biochemical
and histologic techniques.
Results: Aortic dilatation at both 4 and 8 weeks was inhibited in group A (dilatation ratio [%] at 4 weeks: 186.2 6 21.8
in group C, 152.36 10.2 in group G, 126.86 11.6 in group A; P < .0001; dilatation ratio [%] at 8 weeks: 219.36 37.5
in group C, 194.0 6 11.6 in group G, 145.7 6 8.3 in group A; P [ .0002). Elastin and collagen content were
signiﬁcantly preserved in group A (elastin, P[ .0015; collagen, P < .0001). The messenger RNA expressions of matrix
metalloproteinase (MMP)-9, monocyte chemotactic protein-1, interleukin-1b, and tissue necrosis factor-a (P[ .0024,
P < .0001, P < .0001, and P < .0001, respectively) were downregulated in group A (P [ .0024), whereas tissue
inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 were both upregulated in group A (TIMP-1, P[ .0014; TIMP-
2, P < .0001). Gelatin zymography showed activities of pro-MMP-2, MMP-2, and MMP-9 were signiﬁcantly suppressed
in group C (P < .0001 for each). Reactive oxygen species expression and 8-hydroxydeoxyguanosine and cluster
of differentiation 68 staining were signiﬁcantly suppressed in group A (reactive oxygen species expression, P < .0001;
8-hydroxydeoxyguanosine-positive cells, P < .0001; cluster of differentiation 68 positive cells, P < .0001).
Conclusions: Controlled release of ascorbic acid using gelatin hydrogel sheet-attenuated AAA formation through anti-
oxidant and anti-inﬂammatory effect, regulation of MMP-2, TIMP-1, and TIMP-2, and preserving elastin and collagen
in this animal model. (J Vasc Surg 2014;60:749-58.)
Clinical Relevance: Current options for treating abdominal aortic aneurysms are limited to open or endovascular repair. A
simplemethod other than replacement would be highly beneﬁcial to patients. Wrapping the dilated aorta has been reported
to be effective in preventing future dilatation and rupture.Gelatin hydrogel is not only suitable forwrapping vessels but also
is biocompatible and does not cause inﬂammatory changes. Furthermore, it can deliver drugs directly to the target organ
over a period of time with a superior effect than systemic application. Application of an ascorbic acid-impregnated gelatin
hydrogel sheet may enable surgeons to attenuate the future dilatation of abdominal aortic aneurysms in humans.the Department of Surgery, Division of Cardiovascular Surgery, Kobe
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750 Tanaka et al September 2014The pathogenesis of abdominal aortic aneurysms
(AAAs) has been examined in the past decades. Inﬂamma-
tion and tissue degeneration have been proven to play key
roles in this process.1 Moreover, the enhanced oxidative
stress that occurs during the inﬂammatory response has
been demonstrated to contribute to the formation of
AAAs.2,3
Ascorbic acid has powerful antioxidant properties and
can protect tissue from oxidative damages.4 This com-
pound provides a vascular defense against oxidative stress
by scavenging free radicals and by increasing endothelial
nitric oxide synthase activity.5 In addition, ascorbic acid
has been reported to enhance elastin and collagen pro-
duction from aortic smooth muscle cells, and these two
proteins have been demonstrated to be crucial components
of the vascular structure in previous in vitro studies.6-8
Gelatin hydrogel sheets have been demonstrated to
provide stable release of several substances9-11 and to
have excellent vessel-ﬁtting characteristics, with the effect
of circumferential mechanical support, improving structural
and physiological properties.12 This material and method-
ology can prolong the effect of the medication in a target
tissue selectively and continuously. Furthermore, it has
a great potential to provide superior therapeutic efﬁcacy
for topical pharmacologic applications on aneurysmal
vessels compared with systemic application.13
In the current study, we hypothesized that wrapping
gelatin hydrogel sheets to provide sustained release of
ascorbic acid could attenuate aneurysmal development by
both protecting against oxidative stress and by promoting
elastin and collagen production.
METHODS
In vivo controlled release of ascorbic acid from
gelatin hydrogel sheet. The gelatin used in the present
study was isolated using an alkaline process from bovine
bone with an isoelectric point of 4.9 and molecular mass of
99 000 kDa (Nitta Gelatin Co, Osaka, Japan). The gelatin
sheets were prepared by chemical cross-linking of a 5%
bovine bone gelatin solution with glutaraldehyde. Gelatin
sheets of 20 mm2/0.3 mm were prepared and immersed in
50 mmol/L glycine aqueous solution at 37C for 1 hour to
block the residual aldehyde groups of glutaraldehyde. The
sheets were then freeze-dried and sterilized by ethylene
oxide gas. Ascorbic acid (Wako Pure Chemical Industries
Ltd, Osaka, Japan) was incorporated into the gelatin
hydrogel sheets by immersion in a 200-mg/mLascorbic acid
solution for 30 minutes. The release test was performed in
a 1-mL phosphate-buffered saline solution containing 0.01
weight% TWEEN 80 (Sigma-Aldrich, Tokyo, Japan) by
soaking a 5- by 5-mm ascorbic acid-impregnated gelatin
hydrogel sheet to assess the concentration of ascorbic acid at
12, 24, 48, 72, 96, and every 48 subsequent hours, up to
336hours. The sheetwas removed at each end point, and the
solution was combined with 1 mL of 10% metaphosphoric
acid and centrifuged. The supernatant was used for the assay
using a Vitamin C Assay Kit (Cosmo Bio Co, Ltd, Tokyo,
Japan), following the instructions for use. An oxidizingagent was added to each sample, which was incubated for
5 minutes at room temperature. Next, 5% metaphosphoric
acid/2% stannum chloride was added to the sample. After
the addition of 2, 4-dinitrophenylhydrazine to the sample
and 3 hours of incubation at 37C, 85% sulfate was added.
Lastly, the samples were transferred to 96-well plates, and
the absorbance of each sample wasmeasured at 530 nm. To
determine the amount of ascorbic acid in each sample, the
absorbance value of each sample was compared with a set of
standard ascorbic acid samples that were prepared in
parallel.
In vivo controlled release of ascorbic acid from
gelatin hydrogel sheet. A 5- by 10-mm ascorbic acid-
impregnated gelatin hydrogel sheet was implanted subcu-
taneously in four separate parts of the body, left and right
side of the back and chest and abdomen, in three rats to
assess the concentration of ascorbic acid in tissue. At 10,
24, 108, and 216 hours, the sheet was removed and the
subcutaneous tissue was taken and was weighed. Then
the sample was homogenized with 5.4% metaphosphoric
acid and centrifuged. The supernatant was used for the
assay using a Vitamin C Assay Kit (Cosmo Bio Co, Ltd,
Tokyo, Japan).
Animal model. In the present study, 8-week-old male
Sprague-Dawley rats (SLC Inc, Shizuoka, Japan) (n ¼ 54)
were used and handled according to the Guidelines for
Animal Experiments at Kobe University Graduate School
of Medicine (permission number P080120) and the Guide
for the Care and Use of Laboratory Animals (http://www.
nap.edu/catalog/5140.html).
The experimental AAA saccular model was described
previously.14 Brieﬂy, a 1-cm segment of the infrarenal
abdominal aorta was exposed via a midline laparotomy.
Subsequently, the aorta was ﬁlled with 30 mL (30 U) of
porcine pancreatic elastase (135 U/mg; Elastin Products
Company, Owensville, Mo) and 0.5 M CaCl2 (Sigma-
Aldrich, Tokyo, Japan) soaked gauze was wrapped around
the region simultaneously for 20 minutes. The abdominal
incisionwas closed in layers, and ratswere allowed to recover.
Ascorbic acid impregnates hydrogel sheet adminis-
tration. Ascorbic acid was incorporated into the gelatin
hydrogel sheets by immersion in a 200-mg/mL ascorbic
acid solution for 30 minutes prior to implantation.
Following elastase infusion and calcium chloride exposure
of the abdominal aorta, the rats were further treated
according to each group. For group C, (control group),
the abdomen was closed in layers without any additional
procedure. For group G, the treated aorta was wrapped cir-
cumferentially with a 5- by 10-mm plain gelatin hydrogel
sheet that was submerged in natural saline for 30 minutes.
For group A, the treated aorta was enveloped with a 5- by
10-mm ascorbic acid-incorporated gelatin hydrogel sheet.
The 1-week samples (n ¼ 6 in each group) were used
for the molecular analyses, immuohistochemical analyses,
and in situ imaging. The 4-week samples (n ¼ 6 in each
group) were used for the morphometric, histologic, and
quantitative analyses. The 8-week samples (n ¼ 6 in each
group) were used for the morphometric analyses.
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tized, and the abdominal aorta was exposed and photo-
graphed using a digital camera (Leica IC D; Leica
Microsystems, Wetzlar, Germany). The maximal dimen-
sion of the transverse minor axis of the abdominal aorta
and the aortic diameter at the infrarenal proximal neck
site were measured under physiologic conditions using an
optical micrometer prior to isolation. The dilation ratio
was calculated according to the following formula: dilation
ratio (%) ¼ [maximal aneurysm diameter/native aortic
diameter]  100. AAA was deﬁned as when the dilation
ratio exceeded 150%.
Specimen preparation. The treated 1-cm aortic
segments in each group were isolated at each study end
point. The 1-week aortic segment was cut into two equal
portions transversely. One segment was used for messenger
RNA (mRNA) analysis, and the remaining portion was
further bisected for the immunohistochemical analysis.
The ﬁrst portion was ﬁxed in 10% formalin, dehydrated in
a graded ethanol bath, cleaned in xylene, and parafﬁn-
embedded. The remainder was embedded in Tissue-Tek
O.C.T. compound (Sakura Finetek Japan Co, Tokyo,
Japan) in liquid nitrogen and stored at 80C until
required. The 4-week aortic segments were bisected for
histologic assessment and quantiﬁcation of elastin and
collagen. The 4-week aortic segments for the histologic
analysis were ﬁxed in 10% formalin, dehydrated in a graded
ethanol bath, cleaned in xylene, and parafﬁn-embedded.
Histology. Parafﬁn-embedded 5-mm-thick sections
were stained by hematoxylin and eosin for general appear-
ance, with elastic Van Gieson for elastin and with picrosir-
ius red (PSR) for collagen. The images for the sections
were captured with a microscopic system Biozero (Key-
ence Co, Osaka, Japan) and were assessed using BZ-
H1M (Keyence) and Image J 1.41 software (National
Institutes of Health, Bethesda, Md). The areas of collagen
in a cross-sectional aortic wall were semiquantiﬁed using
Image J plug-in color counter with a color threshold
mask. The collagen content was calculated by dividing the
collagen-positive area by the cross-sectional aortic wall
area in the PSR-stained sections. The method that was
used for this analysis was described by Perrée et al.15 The
collagen content was expressed as a percentage of the total
area.
Quantiﬁcation of elastin. The rat aortic elastin
content was quantiﬁed using the Fastin elastin assay kit
(Biocolor; www.biocolor.co.uk), following the manufac-
turer’s instructions. Brieﬂy, the rat aorta samples were
homogenized in 0.25-M oxalic acid. After centrifuging,
the supernatants were treated with an elastin-precipitating
reagent and centrifuged. After discarding the superna-
tants, the elastin pellet was treated with a dye reagent that
binds to elastin. Lastly, the bound dye-elastin complex was
resuspended, and the dye was disassociated from the
elastin. The absorbance of each sample was measured at
513 nm and compared with a set of standard elastin
samples. The elastin content of each rat aorta sample was
expressed as a percentage of the dry weight of the vessel.Immunohistochemistry. The immunohistochemical
staining was performed on parafﬁn-embedded sections of
1-week samples of the aorta using monoclonal antibody
that is speciﬁc for 8-hydroxydeoxyguanosine (8-OHdG)
(Japan Institute for the Control of Aging, Shizuoka, Japan),
which marks oxidative DNA damage,16 for cluster of
differentiation (CD)68 for macrophages and for monocyte
chemotactic protein (MCP)-1 (Santa Cruz Biotechnology,
Inc, Dallas, Tex). Brieﬂy, deparafﬁnized sections were
incubated overnight at 4C with a primary antibody against
8-OHdG (5.0 mg/mL), CD68 (1.0 mg/mL), and MCP-1
(4.0 mg/mL). Following three washes, the sections were
incubated at room temperature for 30 minutes in a solution
with an anti-mouse IgG secondary antibody (K4001; Dako
Japan Co Ltd, Tokyo, Japan). The microscopic digital
images of ﬁve random ﬁelds on each section were scanned
in a frame that was composed of 500- by 380-mm rectan-
gles, and the number of 8-OHdG-positive cells and CD68-
positive cells in aortic wall was counted using Dynamic cell
count BZ-H1C software (Keyence).
In situ superoxide imaging. The 1-week samples of
aortic wall embedded in Tissue-Tek O.C.T. compound
(Sakura Finetek Japan Co) were cut into 10-mm sections.
Dihydroethidium (DHE) (Invitrogen, Tokyo, Japan) was
used to evaluate tissue superoxide levels in situ, as previ-
ously described.17 The sections were incubated with DHE
in phosphate-buffered saline in a dark, humidiﬁed chamber
for 30 minutes at 37C. DHE ﬂuorescence was detected
through a 580-nm ﬁlter, and DHE ﬂuorescence images of
ﬁve randomly selected ﬁelds on each section were scanned
with Biozero software (Keyence Co) in a frame that was
composed of 500- by 380-mm rectangles. DHE ﬂuores-
cence of the aortic sections was quantiﬁed using Dynamic
cell count BZ-H1C software (Keyence Co). The mean
ﬂuorescence was semiquantiﬁed and expressed relative to
the values that were obtained for native rat tissue.
Quantitative real-time polymerase chain reaction
analysis. Total RNA was isolated from graft samples using
an RNeasy ﬁbrous tissue mini-kit (Qiagen, Valencia, Calif),
following the manufacturer’s instructions. The RNA was
transcribed and ampliﬁed to complimentary DNA (cDNA)
using a high-capacity cDNA reverse-transcription kit
(Applied Biosystems, Foster City, Calif). Quantitative real-
time polymerase chain reaction (PCR) analyses for mRNA
levels of matrix metalloproteinase (MMP)-2, MMP-9,
tissue inhibitors of metalloproteinase (TIMP)-1, TIMP-2,
interleukin (IL)-1b and tumor necrosis factor (TNF)-
a were performed using an ABI Prism 7500 sequence
detection system (Applied Biosystems) with TaqMan
universal PCR master mix (Applied Biosystems) and Taq-
Man real-time PCR primers (Applied Biosystems). The
expression levels of each mRNA were divided by the
mRNA level of the housekeeping gene glyceraldehyde-3-
phosphate dehydrogenase.
Gelatin zymography. Proteins from aortic specimens
were extracted using a buffer containing 50-mM Tris-HCl
(pH 7.5), 150-mM NaCl, 1% Triton X-100, 0.2% sodium-
dodecyl sulfate, and 1-mM ethylenediaminetetraacetic
Fig 1. A, The in vitro controlled release test of ascorbic acid over time. B, The in vivo controlled release test of ascorbic
acid over time.
Fig 2. A, The photographs show treated lesions of abdominal aorta at 4 weeks in each group. Group A, Ascorbic acid-
impregnated gelatin hydrogel; Group C, control; Group G, saline-impregnated gelatin hydrogel. B, Dilatation ratio (%)
at 4 and 8 weeks.
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aprotinin, 10-mg/mL leupeptin, and 1-mM phenylmeth-
ylsulfonyl ﬂuoride). To determine gelatinolytic activities of
MMP-2 and MMP-9 in the treated aorta, gelatin-
zymography kit (Primary Cell Co, Hokkaido, Japan) was
used according to the manufacturer’s instructions. The
protein concentration was standardized with a micro-
bicinchoninic acid protein assay kit (Pierce, Rockford, Ill),
and then protein (20 mg) was applied in each lane for theelectrophoresis. Densitometric analysis of the lytic bands
was performed by Image J software.
Statistical analysis. The database management and
statistical analysis were performed using JMP software
(SAS Institute Inc, Cary, NC). All of the values are
expressed as the means 6 standard deviation of the mean
of the obtained values for each rat in a given group. The
comparisons between multiple groups were performed
using one-way analysis of variance, followed by the
Fig 3. Histologic ﬁndings of abdominal aorta cross-sections at 4 weeks after staining with hematoxylin eosin (H&E)
and elastic van Gieson (EVG) for the morphologic assessment and with picrosirius red (PSR) for the collagen content
assessment. The upper rows are at the original magniﬁcation (40; bar, 300 mm), and the lower panels are at the
original magniﬁcation (400; bar, 100 mm). Group A, Ascorbic acid-impregnated gelatin hydrogel; Group C, control;
Group G, saline-impregnated gelatin hydrogel; Native, normal rats.
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of P < .05 was considered to be statistically signiﬁcant.RESULTS
Release test. In vitro release test demonstrated that
ascorbic acid was rapidly released from gelatin hydrogel
sheets during the ﬁrst 48 hours and was gradually released
over a period of several weeks (Fig 1, A). The concen-
tration of ascorbic acid reached 30 mg/mL, and the sheet
did not dissolve in phosphate-buffered saline at the
completion of the 14-day release test. On the contrast,
in vivo release test showed the ascorbic acid concentration
of tissue was maintained around 100 mg/mL for days
(Fig 1, B). The actual sheet wrapped around the abdom-
inal aorta in rat retroperitoneum was clearly present at
1 week and was barely detected at 4 weeks, then
completely dissolved at 8 weeks.Macroscopic assessments. Aneurysm formation was
observed at 4 and 8 weeks. The macroscopic ﬁndings are
given in Fig 2. According to the AAA deﬁnition in the
present study, AAAs formed in 100% of the rats in group C
at both 4 and 8 weeks. Among rats in group G, 83.3%
exhibited AAA formation at 4 weeks, and 100% exhibited
AAAs at 8 weeks. None of the rats in group A had devel-
oped AAAs at 4 weeks, and only 16.7% formed AAAs at
8 weeks. Signiﬁcant differences were observed in the AAA
formation rates at 4 and 8 weeks in group A compared with
groups C (at 4 weeks, P ¼ .0005; at 8 weeks, P < .0001)
and G (at 4 weeks, P ¼ .0034; at 8 weeks, P ¼ .0118). The
dilation ratios of the AAAs at 4 and 8 weeks were also
signiﬁcantly lower in group A (126.8 6 11.6% at 4 weeks,
145.7 6 8.3% at 8 weeks) than those that were observed in
groups C (186 6 21.8% at 4 weeks, P < .001; 219.3 6
37.5% at 8 weeks, P < .0001) and G (152.3 6 10.2% at
4 weeks, P ¼ .0034; 194.06 11.6% at 8 weeks, P ¼ .0025).
el
as
tin
(µ g
/tis
su
e
w
e i
gh
t m
g )
NS
P = .0021
P = .048
A
0
20
40
60 15
10
 5
  0
NS
P < .001
C
o
lla
ge
n
 
(%
)
B
Native   C              G             A   
Group
Native   C             G             A   
Group
P < .001
Fig 4. The quantiﬁcation of elastin (A) and collagen (B) at 4 weeks. All of the data are expressed as the
mean 6 standard deviation for six rats in each group. Group A, Ascorbic acid-impregnated gelatin hydrogel; Group C,
control; Group G, saline-impregnated gelatin hydrogel; Native, normal rats; NS, not signiﬁcant.
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revealed various degrees of degeneration and disruption
of the elastic lamellae in all the groups C, G, and A
(Fig 3). The elastin, however, content in group A was
signiﬁcantly preserved compared with groups C and G
(elastin [mg/tissue weight mg]: 31.0 6 1.6 in group C,
37.3 6 6.9 in group G, 47.4 6 11.8 in group A; Fig 4, A).
PSR staining demonstrated preserved wall thickness,
with high collagen contents, in group A compared with
the other two groups (Fig 3). The semiquantiﬁcation of
collagen content revealed that group A contained signiﬁ-
cantly higher collagen levels compared with groups C
and G (collagen positive area (%): 4.7 6 0.4 in group C,
3.9 6 0.4 in group G, 9.2 6 0.4 in group A; Fig 4, B).
Antioxidant effect of ascorbic acid. The DHE stain-
ing revealed that relative ROS expression in the aortic wall
was signiﬁcantly suppressed in group A, especially in the
outer layer of the aorta (Fig 5, A), compared with
groups C and G (4.6 6 0.7 in group C, 4.2 6 0.4 in
group G, 1.8 6 0.2 in group A; Fig 5, B). Similarly, the
number of 8-OHdG-positive cells in the aortic walls was
signiﬁcantly decreased in group A compared with groups
C and G (131.3 6 16.1 cells in group C, 121.8 6 16.1
cells in group G, 75.3 6 24.2 cells in group A; Fig 5,
A and C).
Inﬂammatory response. Inﬂammation is believed to
contribute to the etiology of MMP-regulated and
TIMP-regulated AAA formation. The mRNA expression
levels of MMP-2 were similar in all three of the groups
(Fig 6, A). However, the mRNA expressions of MMP-9
were signiﬁcantly downregulated in group A compared
with both groups C and G (2.36 6 0.30 in group C,
2.30 6 1.52 in group G, 0.40 6 0.17 in group A). In
contrast, the mRNA expression levels of TIMP-1 and
TIMP-2 were signiﬁcantly upregulated in group A
compared with both group C and group G. The mRNA
expression levels of TIMP-1 and TIMP-2 in groups A, C,
and G were 0.52 6 0.15 and 0.41 6 0.09, 0.83 6 0.38
for TIMP-1, respectively (Fig 6, A). These values were
0.35 6 0.07, 0.52 6 0.06, and 2.97 6 0.77 for TIMP-2,respectively. In addition, the mRNA expression levels of
inﬂammatory cytokines, MCP-1, IL-1b, and TNF-a, were
all downregulated in group A (MCP-1: 0.31 6 0.07 in
group C, 0.26 6 0.05 in group G, 0.13 6 0.02 in group
A, IL-1b: 1.93 6 0.18 in group C, 0.42 6 0.25 in group
G, 0.176 0.18 group A, TNF-a: 2.436 0.17 in group C,
0.76 6 0.20 in group G, 0.20 6 0.10 in group A; Fig 7,
A). Similarly in CD68 staining, the number of positive
cells in the aortic walls was signiﬁcantly decreased in
group A (87.8 6 28.1 cells in group C, 46.8 6 9.5 cells in
group G, 17.2 6 6.4 cells in group A; Fig 7, B and C).
The distribution of MCP-1 was also reduced in group A.
Moreover, MMP activity was evaluated by gelatin
zymography (Fig 6, B) and group A were signiﬁcantly
downregulated in all the pro-MMP-2, MMP-2, and
MMP-9 activities (Fig 6, C).
DISCUSSION
The current study demonstrated that wrapping an
ascorbic acid-saturated gelatin hydrogel sheet around the
aorta prevented AAA formation in a rat model. This effect
was mediated by an increased level of antioxidant in coop-
eration with the reinforcement of the aortic wall via preser-
vation of its elastin and collagen.
In vitro release tests demonstrated that an ascorbic
acid-containing hydrogel sheet could only generate
a concentration of approximately 30 mg/mL, but an in vivo
release test showed the concentration could reach around
100 mg/mL. The biodegradation of the material in vitro
is expected to deliver a higher concentration as Konishi
et al13 showed in their experiment of the gelatin hydrogel.
They demonstrated that the drug contained in a gelatin
hydrogel sheet only released 10% to 30% in the in vitro
test, but with the degradation of gelatin hydrogel in vivo,
the drug was released more and had a superior effect to
topical application. The initial release of ascorbic acid
from the sheet that was observed in the release test is
assumed to be due to the compound on the surface of
the sheet, which was not bound to the gelatin hydrogel.
Previous reports in humans showed that the plasma vitamin
Fig 5. The assessment of oxidative stress in the aortic wall at day 7. A, Abdominal aorta cross-sections at 1 week after
staining with dihydroethidium (DHE) for the in situ imaging of superoxide levels and 8-hydroxydeoxyguanosine
(8-OHdG) staining for the assessment of oxidative DNA damage. Group A, Ascorbic acid-impregnated gelatin
hydrogel; Group C, control; Group G, saline-impregnated gelatin hydrogel; Native, normal rats; Star, inner aortic
lumen. B, The DHE count was semiquantiﬁed and expressed relative to values that were obtained for native rats. All of
the data are expressed as the mean 6 standard deviation for six rats (average of randomly selected ﬁve ﬁelds) in each
group. C, 8-OHdG-positive cell count in a 500- by 380-mm rectangle of the aortic wall. All of the data are expressed as
the mean 6 standard deviation for six rats (average of randomly selected ﬁve ﬁelds) in each group. NS, Not signiﬁcant.
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mately 38 mg/mL, with doses of 3 g for six times daily.18
Thus, direct delivery of ascorbic acid by gelatin hydrogel
can be expected to reach a much higher level of concentra-
tion than that can be reached with oral supplementing.
Elastin and collagen are important load-bearing
components of the aortic wall, and the destruction of these
elements leads to aortic dilatation.19 We conclusively
demonstrated that aortic walls that received a topical appli-
cation of ascorbic acid via a gelatin hydrogel sheet con-
tained larger contents of elastin and collagen and
exhibited preserved morphology in the rat AAA model.
Furthermore, AAA formation was attenuated by this treat-
ment. The elastin and collagen were better preserved by
the antioxidant and anti-inﬂammatory effects of ascorbic
acid and may have been newly produced from aortic
smooth muscle cells. There are several reports that support
this latter hypothesis. Tajima et al8 previously reported thatthe production of tropoelastin was induced by the presence
of ascorbic acid when aorta-derived smooth muscle cells
were cultured. Moreover, Qiao et al6 reported that the
addition of ascorbic acid to the cell culture resulted in pro-
collagen maturation. Ascorbic acid is required in the
proline hydroxylation of both collagen and elastin,20 and
hydroxyproline is crucial for collagen and elastin stability,
which gives strength to the cellular matrix.
Oxidative stress has been demonstrated to play
a signiﬁcant role in human AAA formation and progres-
sion.2 Our group recently reported that the formation
and the development of AAAs were inhibited by the
suppression of ROS production.21 Ascorbic acid is
a well-known antioxidant that cannot be produced in
the human body. We performed a preliminary experiment
in our AAA model (n ¼ 2) with oral ascorbic acid supple-
mentation of 200 mg daily for 2 weeks, but it could not
prevent dilatation of the AAA (dilatation at 4 weeks, 170%
Fig 6. A,Messenger RNA (mRNA) expression of matrix metalloproteinase (MMP), given as a ratio of glyceraldehyde-
3-phosphatedehydrogenase (GAPDH) expression in the abdominal aorta at 1 week. All of the data are expressed as the
mean 6 standard deviation for six rats in each group. Group A, Ascorbic acid-impregnated gelatin hydrogel; Group C,
control; Group G, saline-impregnated gelatin hydrogel;NS, nonsigniﬁcant; TIMP, tissue inhibitor of metalloproteinase.
B, Gelatin zymography documents gelatinolytic activities of pro-MMP-2, MMP-2 and MMP-9. C, Densitometric
analysis of MMP activities. *P < .05, **P < .01, ***P < .001.
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et al22 who previously described in their study that oral
supplementation of antioxidant vitamins had minimal
effects on prevention of an angiotensin II-induced AAA
formation. However, with our method of delivering ascor-
bic acid to the target aorta, the DHE staining of aortic
cross-section in the present study revealed that ROS
expression was apparently suppressed in the outer layer
of the aortic wall. Moreover, fewer 8-OHdG-positive cells
were observed in the aortas exposed to ascorbic acid
compared with the other groups. Both ﬁndings indicate
that the gelatin hydrogel sheet successfully released ascor-
bic acid and had an antioxidant effect.
Both smooth muscle cells and inﬁltrating inﬂammatory
cells produce MMPs. Speciﬁcally, MMP-2 and MMP-9
are crucial in the formation and the development of
AAAs.23 As we described previously, elastase and calcium
chloride-treated control aortas exhibited markedly
increased MMP-2 and MMP-9 activity in whole aortahomogenates.14 The downregulation of TIMP-1 and
TIMP-2 are reported to result in proteolytic extracellular
matrix degradation, a process that also plays a key role in
aneurysm formation.24 In the present study, MCP-1 and
CD68 staining of the AAA wall and mRNA expressions
of MCP-1, IL-1b, TNF-a showed ascorbic acid sheet
successfully suppressed recruitment of inﬂammatory cells
and inﬂammatory responses, and subsequently pro-
MMP-2, MMP-2, and MMP-9 activities were inhibited
by treatment with ascorbic acid-impregnated hydrogel
sheets; an upregulation of TIMP-1 and TIMP-2 was also
observed in the ascorbic acid-treated group.
We performed additional experiments to evaluate the
treatment effect of the ascorbate sheet on existing AAA.
The animals at 1 week following AAA induction were
treated with plain hydrogel sheets (n ¼ 2) and ascorbic
acid-impregnated hydrogel sheets (n ¼ 2). The plain sheet
could not attenuate the AAA progression (dilatation rate at
1 week, 117% and 236%; dilatation rate at 4 weeks, 234%
Fig 7. A, Messenger RNA (mRNA) expressions of inﬂammatory cytokines, given as a ratio of glyceraldehyde-
3-phosphatedehydrogenase (GAPDH) expression in the abdominal aorta at 1 week. All of the data are expressed as the
mean 6 standard deviation for six rats in each group. Group A, Ascorbic acid-impregnated gelatin hydrogel; Group C,
control; Group G, saline-impregnated gelatin hydrogel; IL-1b, interleukin-1 beta; NS, not signiﬁcant; TNF-a, tissue
necrosis factor-alpha. B, Cluster differentiation (CD)68-positive cell count in a 500- by 380-mm rectangle of the aortic
wall. All of the data are expressed as the mean6 standard deviation for six rats (average of randomly selected ﬁve ﬁelds)
in each group. C, CD68 and monocyte chemotactic protein (MCP)-1 staining for assessment of macrophage
recruitment. *P < .05, **P < .01, ***P < .001.
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further dilatation (dilatation rate at 1 week, 113% and
133%; dilatation rate at 4 weeks, 134% and 154%). This
result shows that ascorbic acid impregnated sheets have
possible treatment effect on existing AAAs.
Limitations. The limitation of the present study is
that the elastase and calcium chloride-induced rat AAA
is not completely similar to human AAAs as it lacks several
prominent features of human lesions, such as atheroscle-
rosis and intraluminal thrombosis. However, we demon-
strated that our AAA model is simple, easy to perform,
highly reliable, and reproducibly creates a saccular
aneurysm.14
CONCLUSIONS
We demonstrate that the wrapping of ascorbic acid-
impregnated gelatin hydrogel sheets has signiﬁcant protec-
tive effects against AAA formation in an elastase and
calcium chloride-induced rat AAA model with suppressed
inﬂammatory response and oxidative stress. Ascorbic acid
treatment has a possible positive effect on elastin andcollagen preservation and production. This treatment also
had a protective effect against oxidative stress.
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